| [1] |
Luger A, Broersen LA, Biermasz NR, et al. ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy[J]. Eur J Endocrinol, 2021, 185(3): G1-G33. DOI: 10.1530/EJE-21-0462.
|
| [2] |
Asa SL, Mete O, Perry A, et al. Overview of the 2022 WHO classification of pituitary tumors[J]. Endocr Pathol, 2022, 33(1): 6-26. DOI: 10.1007/s12022-022-09703-7.
|
| [3] |
|
| [4] |
Glezer A, Bronstein MD. Prolactinomas in pregnancy: considerations before conception and during pregnancy[J]. Pituitary, 2020, 23(1): 65-69. DOI: 10.1007/s11102-019-01010-5.
|
| [5] |
Kuhn E, Weinreich AA, Biermasz NR, et al. Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature[J]. Eur J Endocrinol, 2021, 185(1): 99-108. DOI: 10.1530/EJE-21-0145.
|
| [6] |
Petersenn S. Management des prolaktinoms vor, während und nach der schwangerschaft [Management of prolactinoma prior to, during, and after pregnancy][J]. Dtsch Med Wochenschr, 2023, 148(7): 371-379. DOI: 10.1055/a-1847-2500.
|
| [7] |
Barraud S, Guédra L, Delemer B, et al. Evolution of macroprolactinomas during pregnancy: a cohort study of 85 pregnancies[J]. Clin Endocrinol (Oxf), 2020, 92(5): 421-427. DOI: 10.1111/cen.14162.
|
| [8] |
Levin G, Rottenstreich A. Prolactin, prolactin disorders, and dopamine agonists during pregnancy[J]. Hormones (Athens), 2019, 18(2): 137-139. DOI: 10.1007/s42000-018-0071-z.
|
| [9] |
Pasyechko N, Naumova L, Krytskyy T, et al. Successful treatment of a prolactinoma (case report)[J]. Georgian Med Issues, 2019(287): 26-29.
|
| [10] |
Sant′ Anna BG, Musolino NRC, Gadelha MR, et al. A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas[J]. Pituitary, 2020, 23(2): 120-128. DOI: 10.1007/s11102-019-01008-z.
|
| [11] |
List EO, Berryman DE, List BP, et al. Early investigations of 20-kDa human placental GH show promise[J]. Endocr Metab Immune Disord Drug Targets, 2023 May 15. DOI: 10.2174/1871530323666230515153130. Online ahead of print.
|
| [12] |
Bandeira DB, Olivatti TOF, Bolfi F, et al. Acromegaly and pregnancy: a systematic review and Meta-analysis[J]. Pituitary, 2022, 25(3): 352-362. DOI: 10.1007/s11102-022-01208-0.
|
| [13] |
Vialon M, Grunenwald S, Mouly C, et al. Gestational diabetes and acromegaly: single-centre experience of 14 pregnancies[J]. Clin Endocrinol (Oxf), 2019, 91(6): 805-809. DOI: 10.1111/cen.14097.
|
| [14] |
Popescu AD, Carsote M, Valea A, et al. Approach of acromegaly during pregnancy[J]. Diagnostics (Basel), 2022, 12(11): 2669. DOI: 10.3390/diagnostics12112669.
|
| [15] |
Chanson P, Vialon M, Caron P. An update on clinical care for pregnant women with acromegaly[J]. Expert Rev Endocrinol Metab, 2019, 14(2): 85-96. DOI: 10.1080/17446651.2019.1571909.
|
| [16] |
Huang W, Molitch ME. Pituitary tumors in pregnancy[J]. Endocrinol Metab Clin North Am, 2019, 48(3): 569-581. DOI: 10.1016/j.ecl.2019.05.004.
|
| [17] |
Petersenn S, Christ-Crain M, Droste M, et al. Pituitary disease in pregnancy: special aspects of diagnosis and treatment？[J]. Geburtshilfe Frauenheilkd, 2019, 79(4): 365-374. DOI: 10.1055/a-0794-7587.
|
| [18] |
Jolly K, Darr A, Arlt W, et al. Surgery for Cushing′s disease in pregnancy: our experience and a literature review[J]. Ann R Coll Surg Engl, 2019, 101(1): e26-e31. DOI: 10.1308/rcsann.2018.0175.
|
| [19] |
Hamblin R, Coulden A, Fountas A, et al. The diagnosis and management of Cushing′s syndrome in pregnancy[J]. J Neuroendocrinol, 2022, 34(8): e13118. DOI: 10.1111/jne.13118.
|
| [20] |
Brue T, Amodru V, Castinetti F. Management of endocrine disease: management of Cushing′s syndrome during pregnancy: solved and unsolved questions[J]. Eur J Endocrinol, 2018, 178(6): R259-R266. DOI: 10.1530/EJE-17-1058.
|
| [21] |
Patel MA, Aliporewala VM, Patel DA. Common antifungal drugs in pregnancy: risks and precautions[J]. J Obstet Gynaecol India, 2021, 71(6): 577-582. DOI: 10.1007/s13224-021-01586-8.
|
| [22] |
Chaiamnuay S, Moster M, Katz MR, et al. Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy[J]. Pituitary, 2003, 6(2): 109-113. DOI: 10.1023/b:pitu.0000004802.47010.00.
|
| [23] |
|
| [24] |
Blackhurst G, Strachan MW, Collie D, et al. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy[J]. Clin Endocrinol (Oxf), 2002, 57(3): 401-404. DOI: 10.1046/j.1365-2265.2002.01549.x.
|
| [25] |
Barsi á, Beke A, Sármán B. Case report: a particularly rare case of endogenous hyperinsulinemic hypoglycemia complicated with pregnancy treated with short-acting somatostatin analog injections[J]. Front Endocrinol (Lausanne), 2022, 13: 964481. DOI: 10.3389/fendo.2022.964481.
|
| [26] |
Deutschbein T, Jaursch-Hancke C, Knappe UJ, et al. First german guideline on diagnostics and therapy of clinically non-functioning pituitary tumors[J]. Exp Clin Endocrinol Diabetes, 2021, 129(3): 250-264. DOI: 10.1055/a-1373-4087.
|
| [27] |
Karaca Z, Yarman S, Ozbas I, et al. How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey[J]. J Endocrinol Invest, 2018, 41(1): 129-141. DOI: 10.1007/s40618-017-0709-8.
|
| [28] |
Rosmino J, Tkatch J, Di Paolo MV, et al. Non-functioning pituitary adenomas and pregnancy: one-center experience and review of the literature[J]. Arch Endocrinol Metab, 2021, 64(5): 614-622. DOI: 10.20945/2359-3997000000232.
|
| [29] |
Flitsch J, Burkhardt T. Non-functioning pituitary tumors: any special considerations during pregnancy？[J]. Minerva Endocrinol, 2018, 43(4): 430-434. DOI: 10.23736/s0391-1977.17.02784-5.
|
| [30] |
Noyola-Martínez N, Halhali A, Barrera D. Steroid hormones and pregnancy[J]. Gynecol Endocrinol, 2019, 35(5): 376-384. DOI: 10.1080/09513590.2018.1564742.
|
| [31] |
|